The Fort Worth Press - Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

USD -
AED 3.672502
AFN 65.506901
ALL 80.542786
AMD 365.404028
AOA 917.999947
ARS 1490.933797
AUD 1.416631
AWG 1.8025
AZN 1.704684
BAM 1.694742
BBD 2.013422
BDT 123.409934
BHD 0.376932
BIF 2988.332445
BMD 1
BND 1.280355
BOB 11.871288
BRL 5.174302
BSD 0.999614
BTN 95.355034
BWP 13.493408
BYN 2.963637
BYR 19600
BZD 2.010476
CAD 1.392785
CDF 2274.999813
CHF 0.811735
CLF 0.023224
CLP 914.020134
CNY 6.745297
CNH 6.74767
COP 3137.03
CRC 453.271291
CUC 1
CUP 26.5
CVE 95.544878
CZK 21.02415
DJF 178.017322
DKK 6.479402
DOP 58.290116
DZD 132.998787
EGP 50.179803
ERN 15
ETB 161.696178
EUR 0.86671
FJD 2.21245
FKP 0.739377
GBP 0.740346
GEL 2.615021
GGP 0.739377
GHS 11.761444
GIP 0.739377
GMD 73.502808
GNF 8778.535005
GTQ 7.626087
GYD 209.359254
HKD 7.846499
HNL 26.793985
HRK 6.5302
HTG 130.704343
HUF 316.521009
IDR 17864
ILS 2.997301
IMP 0.739377
INR 95.42005
IQD 1309.573325
IRR 1374700.000461
ISK 123.070381
JEP 0.739377
JMD 158.156744
JOD 0.709021
JPY 159.423999
KES 129.330412
KGS 87.449818
KHR 4050.066938
KMF 427.000292
KRW 1417.544958
KWD 0.30891
KYD 0.832994
KZT 466.161244
LAK 22554.384323
LBP 89518.610465
LKR 334.287955
LRD 180.434905
LSL 16.22219
LTL 2.95274
LVL 0.60489
LYD 6.374968
MAD 9.261597
MDL 17.36399
MGA 4301.39206
MKD 53.312479
MMK 2099.437721
MNT 3594.800745
MOP 8.079183
MRU 39.955635
MUR 47.039473
MVR 15.449606
MWK 1733.381281
MXN 17.064503
MYR 4.093802
MZN 63.399706
NAD 16.220855
NGN 1361.770302
NIO 36.783342
NOK 9.491104
NPR 152.566385
NZD 1.703855
OMR 0.384495
PAB 0.999614
PEN 3.379519
PGK 4.485921
PHP 61.317007
PKR 277.479994
PLN 3.72915
PYG 5952.056011
QAR 3.644076
RON 4.539801
RSD 101.716976
RUB 82.449298
RWF 1472.472911
SAR 3.747756
SBD 8.065041
SCR 13.894089
SDG 600.502876
SEK 9.528796
SGD 1.28069
SLE 24.497323
SOS 571.29488
SRD 37.946011
STD 20697.981008
STN 21.229307
SVC 8.746664
SZL 16.212539
THB 33.119716
TJS 9.211859
TMT 3.51
TND 2.935103
TRY 47.757302
TTD 6.769484
TWD 32.211699
TZS 2654.997973
UAH 44.852497
UGX 3719.156864
UYU 40.24973
UZS 11886.069807
VES 760.265199
VND 26127.5
VUV 118.84778
WST 2.733733
XAF 568.398113
XAG 0.015209
XAU 0.000227
XCD 2.70255
XCG 1.801671
XDR 0.706905
XOF 568.398113
XPF 103.341305
YER 237.200169
ZAR 16.18805
ZMK 9001.200395
ZMW 18.743474
ZWL 321.999592
  • CMSD

    -0.0600

    21.63

    -0.28%

  • CMSC

    -0.1300

    21.44

    -0.61%

  • RBGPF

    2.2800

    72.16

    +3.16%

  • RELX

    -0.2500

    35.37

    -0.71%

  • RIO

    -0.9200

    100.99

    -0.91%

  • NGG

    0.7900

    80.27

    +0.98%

  • BCC

    0.7800

    85.53

    +0.91%

  • BCE

    0.8300

    23.37

    +3.55%

  • JRI

    0.0000

    12.73

    0%

  • GSK

    -1.2600

    50.9

    -2.48%

  • BTI

    -0.2400

    56.81

    -0.42%

  • BP

    0.2800

    43.16

    +0.65%

  • RYCEF

    -0.0200

    20.55

    -0.1%

  • AZN

    -3.1600

    158.75

    -1.99%

  • VOD

    0.1500

    15.9

    +0.94%

Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance
Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

Expanded customer engagements, partnership initiatives, product updates, and industry recognition highlight strong momentum for market leader

Text size:

FRANKLIN, TN / ACCESS Newswire / January 27, 2026 / Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced a record-breaking 2025 marked by a 26% increase in new business, expanded engagements with existing customers, key additions to the executive leadership team, industry recognition, and new partnership initiatives. This momentum underscores the company's rapid growth and position as a comprehensive, outcomes-driven partner that supports health systems in navigating an unpredictable, high-friction payment environment.

In 2025, Revecore achieved its strongest year of growth to date, driven by the addition of new health system clients. These organizations, ranging from community hospitals to multi-state health systems, collectively represent 79 facilities and $91 billion in annual net patient revenue.

At the same time, 24% of Revecore's existing clients increased the scope of their services. Demand for Revecore's denials and receivables offerings was especially strong, with a combined growth of 109% - reflecting the urgency health systems face in managing payer scrutiny, denials, underpayments, and delayed reimbursement. From 2024 to 2025, Revecore increased recovered revenue on behalf of its clients by more than 25%, underscoring consistent performance and focus on client outcomes to address these market pressures.

In response to evolving payer behavior, Revecore continues to invest in its proprietary technology, AI-enabled intelligence, and specialized expertise that helps hospitals protect margins, improve revenue integrity, and achieve greater financial predictability. "Health systems are operating in one of the most challenging reimbursement environments in recent years," said Noah Breslow, CEO of Revecore. "Providers are looking for partners who can help them manage complexity, protect earned revenue, and leverage machine learning and AI to deliver reliable performance across the revenue cycle. Our momentum in 2025 reflects the trust health systems place in Revecore as those pressures continue to intensify."

Revecore's success was further reinforced by independent industry validation. In the 2025 Best in KLAS: Software & Services Report, Revecore earned its fifth consecutive Best in KLAS award for Complex Claims Services, setting a new record in the category and earning all "A's" from clients on customer experience pillars including Loyalty, Operations, Relationship, Services, and Value.

Revecore also made strategic operations and leadership updates - it rolled out a unified support model to deliver a more consistent, coordinated client experience across service lines, and appointed a new Chief Operations Officer and Chief Customer Officer to support immediate priorities and long-term goals.

Another 2025 highlight for Revecore was the launch of its partnership program, designed to connect organizations with aligned capabilities across the hospital ecosystem to support customers through deep, seamless integrations and data-driven insights, fostering collaboration and innovation.

"Revenue cycle complexity doesn't come from a single problem - it comes from how denials, underpayments, complex claims, and receivables intersect differently for every organization," said Wes Pass, CRO, Data Marshall. "Through the Revecore partner program, we're able to integrate our capabilities into a broader, outcome-driven approach that helps providers recover earned revenue and bring greater control to their most complex revenue challenges."

Looking ahead, Revecore plans to continue enhancing its service portfolio, technology capabilities, and partner ecosystem in 2026, while deepening relationships with existing clients. The company also expects to announce new initiatives to help health systems adapt to ongoing reimbursement complexity.

About Revecore

Revecore is a trusted partner to 1,300 hospitals and health systems nationwide, specializing in complex revenue cycle management. Purpose-built to master revenue cycle complexity, and informed by decades of operating experience, Revecore combines AI-enabled technology platforms, proprietary claims scoring models, deep clinical and reimbursement expertise, and an outcome-aligned partnership model to deliver outsized financial impact. A five-time Best in KLAS award winner for Complex Claims Services, the company has helped providers recover billions of earned revenue by resolving denials, underpayments and complex claims at scale. For more information or to learn more about Revecore's partner program visit www.revecore.com.

Media Contact:

Karina Stabile
Aria Marketing for Revecore
[email protected]

SOURCE: Revecore



View the original press release on ACCESS Newswire

T.Gilbert--TFWP